Showing results (1591-1600 of 2,323) with videos related to
Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|February 15, 2020
Migraine pathways and the identification of novel therapeutic targetsInnocenzo Rainero, Fausto Roveta, Alessandro Vacca, et al.Expert Opinion on Therapeutic Targets|February 19, 2020
Pre-clinical models of small cell lung cancer and the validation of therapeutic targetsJane S Y Sui, Petra Martin, Steven G GrayExpert Opinion on Therapeutic Targets|November 8, 2019
Aldehyde dehydrogenase-2 as a therapeutic targetMitsuru Kimura, Akira Yokoyama, Susumu HiguchiExpert Opinion on Therapeutic Targets|December 12, 2019
Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?Lukas Clemens Böckelmann, Udo SchumacherExpert Opinion on Therapeutic Targets|February 8, 2020
Targeting genetically-tuned CAFs in pancreatic cancer via perlecan manipulationShona Ritchie, Brooke A Pereira, Claire Vennin, et al.Expert Opinion on Therapeutic Targets|January 9, 2020
Targeting Chikungunya virus by computational approaches: from viral biology to the development of therapeutic strategiesVitor Won-Held Rabelo, Izabel Christina Nunes de Palmer Paixão, Paula Alvarez AbreuExpert Opinion on Therapeutic Targets|February 21, 2020
Cholangiocarcinoma: novel therapeutic targetsKeisaku Sato, Shannon Glaser, Domenico Alvaro, et al.Expert Opinion on Therapeutic Targets|August 22, 2015
Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancySajjadh M J Ali, Raouf A KhalilExpert Opinion on Therapeutic Targets|July 28, 2015
The potential of cholesteryl ester transfer protein as a therapeutic targetThomas Gautier, David Masson, Laurent LagrostExpert Opinion on Therapeutic Targets|October 29, 2019
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinomaShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.Pageof 233